Nothing Special   »   [go: up one dir, main page]

SG11201503369RA - Rsv f prefusion trimers - Google Patents

Rsv f prefusion trimers

Info

Publication number
SG11201503369RA
SG11201503369RA SG11201503369RA SG11201503369RA SG11201503369RA SG 11201503369R A SG11201503369R A SG 11201503369RA SG 11201503369R A SG11201503369R A SG 11201503369RA SG 11201503369R A SG11201503369R A SG 11201503369RA SG 11201503369R A SG11201503369R A SG 11201503369RA
Authority
SG
Singapore
Prior art keywords
prefusion
trimers
rsv
prefusion trimers
Prior art date
Application number
SG11201503369RA
Inventor
Andrea Carfi
Kurt Swanson
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of SG11201503369RA publication Critical patent/SG11201503369RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SG11201503369RA 2012-11-20 2013-11-19 Rsv f prefusion trimers SG11201503369RA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261728498P 2012-11-20 2012-11-20
US201361890086P 2013-10-11 2013-10-11
PCT/EP2013/074169 WO2014079842A1 (en) 2012-11-20 2013-11-19 Rsv f prefusion trimers

Publications (1)

Publication Number Publication Date
SG11201503369RA true SG11201503369RA (en) 2015-06-29

Family

ID=49622826

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201503369RA SG11201503369RA (en) 2012-11-20 2013-11-19 Rsv f prefusion trimers

Country Status (13)

Country Link
US (1) US20150329597A1 (en)
EP (1) EP2922570A1 (en)
JP (1) JP2016501196A (en)
KR (1) KR20150085843A (en)
CN (1) CN104853769A (en)
AU (1) AU2013349778A1 (en)
BR (1) BR112015011389A2 (en)
CA (1) CA2890135A1 (en)
EA (1) EA201590683A1 (en)
IL (1) IL238520A0 (en)
MX (1) MX2015006377A (en)
SG (1) SG11201503369RA (en)
WO (1) WO2014079842A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9738689B2 (en) 2013-03-13 2017-08-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion RSV F proteins and their use
LT2970398T (en) * 2013-03-13 2024-08-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Prefusion rsv f proteins and their use
EP2974739A1 (en) * 2014-07-15 2016-01-20 Novartis AG RSVF trimerization domains
WO2015189425A1 (en) * 2014-06-13 2015-12-17 Glaxosmithkline Biologicals Sa Immunogenic combinations
US20160122713A1 (en) * 2014-10-14 2016-05-05 Medgenics Medical Israel Ltd. Genetically-modified micro-organ secreting a therapeutic peptide and methods of use thereof
US10744193B2 (en) 2015-03-30 2020-08-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunogenic RSV polypeptides
BE1024420B1 (en) 2015-06-12 2018-02-19 Glaxosmithkline Biologicals Sa POLYNUCLEOTIDES AND POLYPEPTIDES OF ADENOVIRUS
JO3555B1 (en) 2015-10-29 2020-07-05 Merck Sharp & Dohme Antibody neutralizing human respiratory syncytial virus
IL260203B2 (en) 2015-12-23 2024-09-01 Pfizer Rsv f protein mutants
CN106119287B (en) * 2016-08-29 2019-10-11 广东华南疫苗股份有限公司 A kind of recombinant vector and method for expressing respiratory syncystial virus F protein
TWI683826B (en) * 2016-11-22 2020-02-01 國立臺灣大學 Recombinant rsv antigens
CN106946994B (en) * 2017-03-09 2019-11-26 中国医学科学院病原生物学研究所 It is a kind of inhibit infection with hepatitis C virus albumen and its application
WO2018172447A1 (en) 2017-03-23 2018-09-27 Alpha-O Peptides Ag Self-assembling protein nanoparticles with built-in six-helix bundle proteins
KR20190135017A (en) * 2017-03-30 2019-12-05 더 유니버서티 어브 퀸슬랜드 Chimeric Molecules and Their Uses
BR112019020661A2 (en) 2017-04-04 2020-05-05 University Of Washington self-assembling protein nanostructures that exhibit paramyxovirus and / or pneumovirus f proteins and their use
JP7253034B2 (en) * 2019-02-28 2023-04-05 Kmバイオロジクス株式会社 RSV F/G chimeric vaccine
CN114502572A (en) 2019-09-04 2022-05-13 华盛顿大学 Self-assembled protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and uses thereof
CN116162136B (en) * 2021-11-24 2024-08-23 成都奥达生物科技有限公司 Anti-syncytial virus membrane fusion inhibitor
WO2023187743A1 (en) * 2022-03-31 2023-10-05 The University Of Queensland Improved chimeric polypeptides and uses thereof
WO2024193380A1 (en) * 2023-03-17 2024-09-26 成都威斯克生物医药有限公司 Vaccine against respiratory syncytial virus infection
CN117304280B (en) * 2023-11-28 2024-04-16 江苏瑞科生物技术股份有限公司 Recombinant RSV F protein and application thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149650A (en) * 1986-01-14 1992-09-22 University Of North Carolina At Chapel Hill Vaccines for human respiratory virus
US5340740A (en) 1992-05-15 1994-08-23 North Carolina State University Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
FR2726003B1 (en) 1994-10-21 2002-10-18 Agronomique Inst Nat Rech CULTURE MEDIUM OF AVIAN TOTIPOTENT EMBRYONIC CELLS, METHOD FOR CULTURING THESE CELLS, AND AVIAN TOTIPOTENT EMBRYONIC CELLS
FR2832423B1 (en) 2001-11-22 2004-10-08 Vivalis EXOGENOUS PROTEIN EXPRESSION SYSTEM IN AN AVIAN SYSTEM
FR2836924B1 (en) 2002-03-08 2005-01-14 Vivalis AVIAN CELL LINES USEFUL FOR THE PRODUCTION OF INTEREST SUBSTANCES
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
HUE029258T2 (en) * 2007-12-24 2017-02-28 Id Biomedical Corp Quebec Recombinant rsv antigens
CA2713879C (en) 2008-02-01 2020-01-07 Alpha-O Peptides Ag Self-assembling peptide nanoparticles useful as vaccines
WO2010009065A2 (en) 2008-07-15 2010-01-21 Novartis Ag Amphipathic peptide compositions
CA2730737A1 (en) 2008-07-15 2010-01-21 Novartis Ag Immunogenic amphipathic peptide compositions
DK2370099T3 (en) 2008-12-09 2016-08-01 Novavax Inc Rsv f modified proteins and methods of their use
CA2766205A1 (en) * 2009-06-24 2010-12-29 Id Biomedical Corporation Of Quebec Vaccine comprising at least two paramyxovirus f protein antigens
PT3178490T (en) 2009-07-15 2022-06-30 Glaxosmithkline Biologicals Sa Rsv f protein compositions and methods for making same

Also Published As

Publication number Publication date
AU2013349778A1 (en) 2015-05-28
IL238520A0 (en) 2015-06-30
EA201590683A1 (en) 2015-11-30
WO2014079842A1 (en) 2014-05-30
KR20150085843A (en) 2015-07-24
CA2890135A1 (en) 2014-05-30
US20150329597A1 (en) 2015-11-19
CN104853769A (en) 2015-08-19
MX2015006377A (en) 2015-07-21
BR112015011389A2 (en) 2017-08-22
EP2922570A1 (en) 2015-09-30
JP2016501196A (en) 2016-01-18

Similar Documents

Publication Publication Date Title
IL238520A0 (en) Rsv f prefusion trimers
HRP20171351T1 (en) Rsv antiviral compounds
IL238185B (en) Albumin variants
GB2507408B (en) Wiper
SG11201405804YA (en) Vaccine against rsv
IL233689A0 (en) Albumin variants
PT2895994T (en) High temperature transponders
HK1201994A1 (en) Connecting element
HK1211486A1 (en) Novel uses
SI2614812T1 (en) Mouthwash
GB2511381B (en) Clasp system
EP2863742A4 (en) Microcapsule
HK1212659A1 (en) Chemical-packed article
GB201502241D0 (en) Absorbent product
PL2872583T3 (en) Adhesive system
EP2894366A4 (en) Impact-absorbing member
HK1206274A1 (en) Vaccine against rsv rsv
GB201216756D0 (en) Glycobiological surfaces
GB201205321D0 (en) Novel pyrimidines
GB201220025D0 (en) Structural element
GB201218152D0 (en) Tracking system
GB201204462D0 (en) Refridgeration module
GB201222528D0 (en) Novel uses
GB201222391D0 (en) Novel Uses
GB201206745D0 (en) N block